OpenEvidence, an ad-supported medical AI startup valued at $15 billion, is gaining traction among doctors

OpenEvidence, an AI startup that answers medical questions, is reportedly seeing rapid growth and is valued at about $15 billion. Its popularity comes amid ongoing questions about the accuracy of its answers. The platform is funded in part by advertising, which has drawn scrutiny over potential conflicts with clinical advice. Many physicians may already be using the tool in their daily practice. The report highlights the tension between the company's commercial model and concerns about reliability in medical information.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in